While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK's proprietary AS01E adjuvant.

GSK plc (GSK, GSK.L) announced Tuesday new data from the AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial evaluating ...

These include the demand and stocking levels for US Arexvy, trends for Shingrix in the US market, and the development of the company's partnership in China. Additionally, the potential impact of ...

The revision comes as the analyst anticipates GlaxoSmithKline's third-quarter sales and profits to likely fall short of consensus estimates, primarily due to weaker than expected performance of US ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Malaysia for respiratory ...

There are now three vaccines available in the US—GSK’s Arexvy and Moderna’s mRESVIA are approved for use in older adults, and Pfizer’s Abrysvo for older adults and pregnant women—but ...

First discovered in chimpanzees in 1956 and in children the following year, respiratory syncytial virus (RSV) isn’t new. Neither is it uncommon among the youngest and oldest populations ...

Major League Baseball's 2024 playoffs are down to eight teams. The ALDS and NLDS began on Saturday with four games. The Guardians blew out the Tigers, 7-0, to open their series and the Mets staged ...

The CDC recommends that all adults 75 years and older, and adults aged 60 to 74 years who are at increased risk for severe RSV disease should receive a single dose of the RSV vaccine (Arexvy [GSK ...

In its update posted this morning, GSK revealed that sales of its Arexvy vaccine came in at £1.24 billion ($1.57 billion) in 2023, including £529 million ($671 million) from the fourth quarter.

In a few cases, pharmacies gave pregnant people GSK’s RSV vaccine for older people, Arexvy, by mistake. That product is not licensed for use in pregnant people. Another problem that occurred on ...